Population
Isolated cardiomyocytes
Comparison
Ca2+ antagonists vs Comparison between slow Ca2+ channel blockers…
Design
Preclinical
Authors
Loading...
Challenges assumption that slow channel blockade prevents Ca2+ overload; hypothesis-generating for non-slow-channel drugs in experimental cardioprotection.
Non-slow-channel-blocking calcium antagonists provide superior protection against cellular degeneration and calcium overload in isolated cardiomyocytes compared to slow channel blockers.
Borgers et al. (1988) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: